COMPANIES
Bipar Sciences
Biomimedica
Capnia
Chimerix
Coapt
InteKrin
iScience Interventional
Koronis

ASSISTANT
Kristine Scott
650.494.7400
assetman.com email: Kristine

Graham joined Asset Management Company in 2000 and is in charge of the life sciences portfolio.

Graham first practiced as a physician in Australia and, after business school, became a Product Manager at Molecular Devices Corporation, a venture-backed, start-up, bio-analytical company. He then worked as a management consultant focused on health-care strategy and operations at the consulting firm of Booz, Allen & Hamilton. In 1992, Graham joined the venture capital group of Dillon Read & Co., a New York investment bank, where he focused on investments in biotechnology and medical device companies. After Dillon Read was acquired by Swiss Bank Corporation in 1997, the venture capital group was spun out to form Ticonderoga Capital, Inc. Graham became a partner of Ticonderoga and led the firm's healthcare investment activity for the next three years.

Graham has a medical degree from the University of Western Australia and he attended the Stanford University Graduate School of Business, where he earned his MBA.

Graham invests in medical device and biotechnology companies. He is a director of the public biotechnology company Insmed, Inc. (NASDAQ: INSM) as well as several private companies.